Currently Recruiting

Screen Shot 2023-01-04 at 9.40.16 am
OCEANIC STROKE

A multicenter, international, randomized, placebo controlled, double-blind, parallel group and event driven Phase 3 study of the oral FXIa inhibitor…

Screen Shot 2022-12-01 at 3.25.02 pm
OCEANIC-AF

A multicenter, international, randomized, active comparator-controlled, double-blind, double-dummy, parallel-group, 2-arm, Phase 3 study to compare the efficacy and safety of…

OPTIMISTmain
OPTIMISTmain

Optimal Post rTpa-Iv Monitoring in Ischemic Stroke Lead PI: Professor Craig Anderson Status: Recruiting, Site selection No. of Patients Currently Recruited: 18 …

Pacific-Stroke
Pacific-Stroke

Phase 2 Program of AntiCoagulation via Inhibition of FXIa by the oral Compound BAY 2433334 – non-cardioembolic STROKE study (PACIFIC-STROKE)…

PESTO

 A Prospective multicentre, phase 2b randomised controlled double-blind trial, to determine the safety and efficacy of perispinal etanercept on quality…

Screen Shot 2023-04-12 at 1.24.16 pm
QASC Australia

QUALITY IN ACUTE STROKE CARE (QASC) AUSTRALIA TRIAL Principal Investigator: Prof Sandy Middleton The Quality in Acute Stroke Care (QASC)…

RECAPS
ReCAPS

Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke ReCAPS: Recovery-focused Community support to Avoid readmissions and improve Participation…

Screen Shot 2022-05-18 at 3.42.17 pm
STARS

Safety and Tolerability of AZD6482 in Reperfusion for Stroke (STARS) Study Lead PI: Dr Candice Delcourt Status: Recruiting No. of…

STOP-MSU

Stopping haemorrhage with Tranexamic acid for hyperacute Onset Presentation including Mobile Stroke Units Lead PI: Prof Stephen Davis, Prof Geoff Donnan,…

TACTICS
TACTICS

Trial of Advance CT Imaging and Combined Education Support for stroke patient access to endovascular therapy (EVT) using a hub…

1 2 3